Genomic Profiling for Precision Medicine: Interview with David Spetzler, Caris Life Sciences
Caris Life Sciences, a Dallas-based innovator in molecular science focused on fulfilling the promise of precision medicine, has developed the MI Genomic Profiling Similarity (GPS) score to compare the molecular characteristics of specific tumors against those in the Caris database. This allows clinicians to identify the molecular subtype of their patients’ tumors and guide personalized… Read More »